Ocean Biomedical, Inc. Stock Nasdaq
Equities
OCEA
US67644P1057
Biotechnology & Medical Research
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 49.03M |
---|---|---|---|---|---|
Net income 2023 * | -92M | Net income 2024 * | -32M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.46
x | P/E ratio 2024 * |
-1.59
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 28.01% |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.31% | 22.2B | |
-16.53% | 21.23B | |
-8.75% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |